Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
7
2015
Dunkin’ Donuts: Your Munchkin Is Showing IMS Legal Strategies
Dec
21
2017
Compounders Who Skirt The FDA: Who Is The Expert Here? IMS Legal Strategies
Sep
4
2015
Wine Seller Victory in Illinois Qui Tam Lawsuit Horwood Marcus & Berk Chartered
Apr
14
2015
A Call to Comment for Telemedicine Stakeholders: The Cadillac Tax Epstein Becker & Green, P.C.
May
23
2023
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
Feb
7
2024
NJ Approves Cannabis Regulatory Amendment with Major Impacts on Class 5 Retail License Holders Epstein Becker & Green, P.C.
Mar
26
2024
Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing Epstein Becker & Green, P.C.
Apr
11
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements Epstein Becker & Green, P.C.
Nov
6
2020
Get Out the Toke: State Ballot Initiatives Legalize Marijuana and More Epstein Becker & Green, P.C.
Feb
4
2022
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts Epstein Becker & Green, P.C.
Nov
15
2018
OIG Publishes Report: FDA’s “Deficient” Cybersecurity Policies and Procedures Need Improvement Epstein Becker & Green, P.C.
Jun
1
2022
Unpacking Averages: Violations Found in Medical Device Warning Letters Epstein Becker & Green, P.C.
Jul
13
2022
FTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector Epstein Becker & Green, P.C.
Jun
4
2019
FDA Hosts Long-Awaited Cannabis Public Hearing Epstein Becker & Green, P.C.
Oct
13
2022
Four Years After Enactment – Clinical Laboratories Should Not Forget About EKRA Epstein Becker & Green, P.C.
Aug
5
2019
Employment Law This Week®: Cannabis User Protections, WHD Opinion Letters, New Salary History Bans, NYS Anti-Harassment Training Deadline [VIDEO] Epstein Becker & Green, P.C.
Aug
4
2015
The Future of Research Using Electronic Medical Records Data: Precision Medicine Initiative Privacy and Trust Guiding Principles Provide Another Piece of the Puzzle Epstein Becker & Green, P.C.
Sep
25
2019
FDA Guidance Clarifies HDE Program Review Epstein Becker & Green, P.C.
Jun
1
2023
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study Epstein Becker & Green, P.C.
Jun
13
2023
An “Overbroad” Noncompete – the NLRB Has Found Its First Target Epstein Becker & Green, P.C.
Apr
3
2020
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic Epstein Becker & Green, P.C.
May
10
2017
Commissioner Scott Gottlieb’s Priorities as Newly Approved FDA Commissioner Epstein Becker & Green, P.C.
Jun
8
2021
New Class Action Litigation Claims That Fish Oil Is The Modern-Day Snake Oil Epstein Becker & Green, P.C.
Jun
25
2018
Cheers to 80 Years: Celebrating the Anniversary of the Federal Food, Drug, and Cosmetic Act Epstein Becker & Green, P.C.
Jan
4
2022
Unpacking Averages: Likelihood of FDA Medical Device Inspections Epstein Becker & Green, P.C.
Jan
19
2022
Video: SCOTUS Decides on Vaccine Rules, Companies Can Still Require Vaccination, Restrictive Covenants in CO – Employment Law This Week Epstein Becker & Green, P.C.
Aug
22
2019
Are Efforts to Speed Up Antitrust Merger Reviews Working? Epstein Becker & Green, P.C.
Aug
1
2023
Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins